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The innate immune system comprises several classes of pattern recognition receptors, including
Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-1-like receptors (RLRs). TLRs recog-
nize microbes on the cell surface and in endosomes, whereas NLRs and RLRs detect microbial
components in the cytosol. Here we discuss the recent understanding in NLRs. Two NLRs, NOD1
and NOD2, sense the cytosolic presence of the peptidoglycan fragments meso-DAP and muramyl
dipeptide, respectively, and drive the activation of mitogen-activated protein kinase (MAPK) and
the transcription factor NF-kB. A different set of NLRs induces caspase-1 activation through the
assembly of large protein complexes named inflammasomes. Genetic variations in several NLR
members are associated with the development of inflammatory disorders. Further understanding
of NLRs should provide new insights into the mechanisms of host defense and the pathogenesis
of inflammatory diseases.The innate immune system recognizes infections through
pattern recognition receptors (PRRs) that detect con-
served microbial components called pathogen-associ-
ated molecular patterns (PAMPs). These PAMPs repre-
sent molecules vital for microbial survival such as
flagellin, nucleic acid structures unique to bacteria and
viruses (CpG DNA, dsRNA), and the bacterial cell-wall
components lipopolysaccharide (LPS), lipoteichoic acid,
and peptidoglycan (Akira et al., 2006). More than a decade
ago, the protein Toll was identified as a key regulator of in-
nate immune signaling in Drosophila melanogaster (Hoff-
mann, 2003). Since then, mammalian Toll-like receptors
(TLRs) have been recognized for their ability to sense
a wide array of microbial and self-ligands at the cell
surface and within endosomes (Kawai and Akira, 2006).
Recent studies identified the nucleotide binding and olig-
omerization domain (NOD)-like receptors (NLRs) and the
RIG-I (retinoid acid-inducible gene I)-like receptors
(RLRs) as two additional innate immune receptor families
that recognize PAMPs in intracellular compartments
(Inohara et al., 2005; Meylan and Tschopp, 2006). The dis-
covery of these cytosolic PRRs suggests that microbes
evading extracellular surveillance encounter another line
of recognition in the host cytosol. The detection of PAMPs
by TLRs, NLRs, and RLRs activates multiple proinflamma-
tory signaling pathways to mount an effective antiviral or
bactericidal response targeting the invading microbe.
Here, we review and discuss recently gained knowledge
on the role of NLRs in immune responses.
The Family of Intracellular Nod-like Receptors
NLRs comprise a large family of intracellular PRRs that are
characterized by the presence of a conserved NOD (Ino-
hara and Nunez, 2001). Notably, the architecture of NLRs
resembles that of a subset of plant disease-resistance (R)genes, which are involved in the hypersensitive response
against virulent plant pathogens (Inohara and Nunez,
2001). The general domain organization of these proteins
includes (1) an N-terminal effector binding region that
consists of protein-protein interaction domains such as
the caspase recruitment domain (CARD), pyrin (PYD),
and baculovirus inhibitor repeat (BIR) domain; (2) an inter-
mediary NOD domain that is required for nucleotide bind-
ing and self-oligomerization; and finally (3) an array of
C-terminal leucine-rich repeat (LRR) motifs to detect con-
served microbial patterns and to modulate NLR activity.
Bioinformatic studies revealed the presence of 23 NLR
genes in the human genome (Harton et al., 2002; Inohara
and Nunez, 2003), whereas at least 34 NLR genes are
present in the mouse genome (Table 1). Based on the
N-terminal domains, NLRs can be classified into three
subfamilies also referred to as CARD-containing NODs,
PYD-containing NALPs, or BIR-containing NAIPs (Table
1). The LRRs in the C terminus of NLR proteins are thought
to fold back onto the NOD domain, thereby inhibiting
spontaneous oligomerization and activation of the NLR
protein (Duncan et al., 2007; Faustin et al., 2007). This
function is reminiscent of the multiple repeats of trypto-
phan and aspartate residues (also known as WD-40
repeats) in the apoptosis regulator Apaf-1 (Acehan et al.,
2002). The current model proposes that when PAMPs are
sensed by the C-terminal LRRs, the molecule undergoes
conformational rearrangements triggering oligomerization
via the NOD domain. In turn, NLRs expose the effector do-
mains to induce the recruitment and activation of CARD-
and PYD-containing effector molecules by promoting their
proximity and oligomerization (Inohara et al., 1999).
Hence, the NLR proteins NOD1 and NOD2 interact with the
serine-threonine kinase RICK (also called Ripk2 or RIP2)
to induce NF-kB and MAPK signaling. Another NLRImmunity 27, October 2007 ª2007 Elsevier Inc. 549
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ReviewTable 1. Human and Murine NLR Genes Organized by Their N-Terminal Domain
NLR Members (HGNC
Symbols)
N Terminus Human Mouse Aliases Domain Organization
CARD CIITA C2TA, NLRA (CARD)-AD-NOD-LRR
CIIta C2TA, Nlra (CARD)-AD-NOD-LRR
NOD1 NLRC1, CARD4, CLR7.1 CARD-NOD-LRR
Nod1 Nlrc1, Card4 CARD-NOD-LRR
NOD2 NLRC2, CARD15, CLR16.3,
BLAU, IBD1, PSORAS1
CARD(2x)-NOD-LRR
Nod2 Nlrc2, Card15 CARD(2x)-NOD-LRR
NLRC4 CARD12, CLR2.1, CLAN, IPAF CARD-NOD-LRR
Nlrc4 Card12, CLAN, Ipaf CARD-NOD-LRR
NLRC3a CLR16.2, NOD3 X-NOD-LRR
Nlrc3 CLR16.2 X-NOD-LRR
NLRC5a CLR19.3, NOD27 X-NOD-LRR
Nlrc5 X-NOD-LRR
NLRX1b CLR11.3, NOD9 X-NOD-LRR
Nlrx1 X-NOD-LRR
PYD NLRP1 NALP1, CARD7, CLR17.1, NAC,
DEFCAP
PYD-NOD-LRR-CARD
Nlrp1a Nalp1 NOD-LRR-CARD
Nlrp1b NOD-LRR-CARD
Nlrp1c NOD-LRR
NLRP2 NALP2, CLR19.9, PYPAF2,
NBS1, PAN1
PYD-NOD-LRR
Nlrp2 Pypaf2, Nbs1, Pan1 PYD-NOD-LRR
NLRP3 NALP3,CIAS1,CLR1.1,PYPAF1,Cryopyrin PYD-NOD-LRR
Nlrp3 Nalp3, Cias1, Pypaf1, Mmig1, Cryopyrin PYD-NOD-LRR
NLRP4 NALP4, CLR19.5, PYPAF4,
RNH2, PAN2
PYD-NOD-LRR
Nlrp4a Nalp4a, Nalp-eta, Nalp9D PYD-NOD-LRR
Nlrp4b Nalp4b, Nalp-gamma, Nalp9E PYD-NOD-LRR
Nlrp4c Nalp4c, Nalp-alpha, Rnh2 PYD-NOD-LRR
Nlrp4d Nalp4d, Nalp-beta PYD-NOD-LRR
Nlrp4e Nalp4e, Nalp-epsilon PYD-NOD-LRR
Nlrp4f Nalp4f, Nalp-kappa, Nalp9F PYD-NOD-LRR
Nlrp4g Nalp4g PYD-NOD-LRR
NLRP5 CLR19.8, PYPAF8, PAN11, MATER PYD-NOD-LRR
Nlrp5 Mater, Op1 NOD-LRR
NLRP6 CLR11.4, PYPAF5, PAN3 PYD-NOD-LRR
Nlrp6 PYD-NOD-LRR
NLRP7 NALP7, CLR19.4, PYPAF3,
NOD12, PAN7
PYD-NOD-LRR
NLRP8 NALP7, CLR19.2, PAN4, NOD16 PYD-NOD-LRR
NLRP9 NALP7, CLR19.1, NOD6, PAN12 PYD-NOD-LRR
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NLR Members (HGNC
Symbols)
N Terminus Human Mouse Aliases Domain Organization
Nlrp9a Nalp9a, Nalp-theta PYD-NOD-LRR
Nlrp9b Nalp9b, Nalp-delta PYD-NOD-LRR
Nlrp9c Nalp9c, Nalp-zeta PYD-NOD-LRR
NLRP10 NALP10, CLR11.1, Pynod,
NOD8, PAN5
PYD-NOD
Nlrp10 Nalp10, Pynod PYD-NOD
NLRP11 NALP11, CLR19.6, PYPAF6,
NOD17, PAN10
PYD-NOD-LRR
NLRP12 NALP12, CLR19.3, PYPAF7,
RNO2, Monarch1, PAN6
PYD-NOD-LRR
Nlrp12 Nalp12 PYD-NOD-LRR
NLRP13 NALP13, CLR19.7, NOD14, PAN13 PYD-NOD-LRR
NLRP14 NALP14, CLR11.2, NOD5, PAN8 PYD-NOD-LRR
Nlrp14 Nalp14, Nalp-iota, GC-LRR PYD-NOD-LRR
BIR NAIP BIRC1, CLR5.1 BIR(3x)-NOD-LRR
Naip1 Birc1a BIR(3x)-NOD-LRR
Naip2 Birc1b BIR(3x)-NOD-LRR
Naip3 Birc1c BIR(3x)-NOD-LRR
Naip4 Birc1d BIR(3x)-NOD-LRR
Naip5 Birc1e BIR(3x)-NOD-LRR
Naip6 Birc1f BIR(3x)-NOD-LRR
Naip7 Birc1g BIR(3x)-NOD-LRR
a These NLRs have been classified as CARD proteins by the Human Genome Gene Nomenclature Committee (HGNC) although it is
unclear whether they contain a CARD, PYD, or another interaction domain in their N terminus based on searches in the NCBI and
SMART domain databases.
b It is currently unclear whether this NLR member encodes a CARD, PYD, or another interaction domain in its N terminus.protein, the CIITA transcription factor, is required for the
transcription of genes encoding MHC II, whereas the NLR
family members Nalp1 and Cryopyrin recruit the adaptor
protein ASC (apoptosis-associated speck-like protein
containing a CARD) to activate caspase-1. Thus, NLRs are
involved in the activation of diverse signaling pathways.
Role of NOD1 and NOD2 in Host Defense
NOD1 and NOD2 sense bacterial molecules produced
during the synthesis and/or degradation of peptidoglycan.
NOD1 recognizes the dipeptide g-D-glutamyl-meso-dia-
minopimelic acid (iE-DAP) (Chamaillard et al., 2003a; Gir-
ardin et al., 2003a), which is produced by most Gram-neg-
ative and specific Gram-positive bacteria (Hasegawa
et al., 2006). In contrast, NOD2 is activated by muramyl di-
peptide (MDP), a component of virtually all types of PGN
(Girardin et al., 2003b; Inohara et al., 2003). Direct or indi-
rect ligand recognition by the LRRs of NOD1 and NOD2 in-
duces the recruitment of RICK through homotypic CARD
interactions (Inohara et al., 1999; Ogura et al., 2001b).
This CARD-containing serine-threonine kinase directlybinds and promotes K63-type polyubiquitylation of the
regulator IKKg and activation of the kinase TAK1 (Abbott
et al., 2004; Windheim et al., 2007), a prerequisite for acti-
vation of the IKK complex. These events result in the deg-
radation of the NF-kB inhibitor IkBa and the subsequent
translocation of NF-kB to the nucleus, where transcription
of NF-kB-dependent target genes occurs (Figure 1). In ad-
dition to the NF-kB pathway, NOD1 or NOD2 stimulation
results in the activation of the MAP kinases p38, ERK, and
JNK (Girardin et al., 2001; Kobayashi et al., 2005; Pauleau
and Murray, 2003; Park et al., 2007). The CARD-containing
adaptor protein CARD9 was found to be important for the
activation of p38 and JNK downstream of NOD2, although
it was dispensable for NF-kB activation (Hsu et al., 2007).
Nevertheless, the NF-kB and MAP kinase pathways are
thought to cooperate to upregulate the expression of
proinflammatory molecules that stimulate both innate
and adaptive immune responses (Figure 1). Previous stud-
ies suggested that RICK is involved in TLR signaling (Ko-
bayashi et al., 2002). However, many preparations of TLR
agonists contain NOD1- and NOD2-stimulating impurities,Immunity 27, October 2007 ª2007 Elsevier Inc. 551
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ReviewFigure 1. Model for PGN Recognition
by NOD1 and NOD2
The NLR proteins NOD1 and NOD2 sense in-
tracellular iE-DAP and MDP, respectively,
leading to recruitment of the adaptor proteins
RICK and CARD9. Extracellular PAMPs are
recognized by TLRs, which signals through
MyD88, IRAK proteins, and TRAF members.
For clarity, the TLR pathway has been simpli-
fied. The subsequent activation of NF-kB and
MAP kinases results in the transcriptional upre-
gulation of proinflammatory genes.and the presence of such contaminants could explain the
reduced TLR signaling observed in RICK-deficient macro-
phages. Indeed, recent studies demonstrated that RICK is
specifically required for NOD1 and NOD2 signaling, but not
for TLR pathways (Park et al., 2007).
In vitro studies indicated that multiple bacteria including
Shigella flexneri (Girardin et al., 2003a), entero-invasive
Escherichia coli (Kim et al., 2004), Chlamydophila pneu-
moniae (Opitz et al., 2005), Campylobacter jejuni (Zilbauer
et al., 2007), and Listeria monocytogenes (Hasegawa
et al., 2006; Park et al., 2007) are sensed by NOD1.
NOD2 has also been implicated in sensing intracellular
pathogens such as Listeria monocytogenes (Kobayashi
et al., 2005), Streptococcus pneumoniae (Opitz et al.,
2004), and Mycobacterium tuberculosis (Ferwerda et al.,
2005). However, studies in Nod1/ and Nod2/ mice
are needed to assess whether these results can be extra-
polated to in vivo models of bacterial infection. In this re-
gard, primary fibroblasts from Nod1/ mice induce lower
expression of proinflammatory genes when infected with
the intracellular bacteria Chlamydia trachomatis, suggest-
ing that NOD1 can detect Chlamydia. However, vaginally
infected Nod1/ mice show normal disease progression,
cytokine secretion, and pathology (Welter-Stahl et al.,
2006), suggesting redundancy with other innate immune
receptors such as Nod2 and TLRs. Nevertheless, the in
vivo relevance of NOD1 and NOD2 for bacterial infections
was clearly demonstrated for Helicobacter pylori and Lis-
teria monocytogenes. For example, mice with a targeted
deletion of the Nod1 gene display an increased suscepti-
552 Immunity 27, October 2007 ª2007 Elsevier Inc.bility to Helicobacter pylori (Viala et al., 2004). This gastric
pathogen is commonly thought to be an extracellular
pathogen, raising the question of how peptidoglycan-
derived iE-DAP and its intracellular sensor NOD1 encoun-
ter each other. Virulent H. pylori strains were found to de-
liver peptidoglycan through a type IV secretion apparatus
(Viala et al., 2004), a molecular syringe used to inject viru-
lence factors directly into the host cytosol. Activation of
NOD1 stimulates the production of chemokines and
the recruitment of neutrophils in vivo (Masumoto et al.,
2006). Moreover,H. pylori-induced production of b-defen-
sins was abolished in Nod1/ mice (Boughan et al.,
2006). Finally, NOD1 has been implicated in priming
antigen-specific T cell responses, thereby contributing
to the onset of adaptive immunity (Fritz et al., 2007),
although the mechanism involved remains poorly under-
stood.
Increased bacterial burdens were also observed in
Nod2/ mice infected orally, but not through the
intravenous and intraperitoneal routes, with Listeriamono-
cytogenes (Kobayashi et al., 2005). The reason for the crit-
ical role of NOD1 and NOD2 in innate immunity at gastro-
intestinal surfaces remains unclear. One possibility is that
the function of TLR and NOD1 or NOD2 to certain patho-
gens is less redundant in intestinal tissues where TLR sig-
naling is downregulated to avoid inflammation induced by
commensal bacteria. Alternatively, NOD1 and NOD2 may
perform unique and critical antibacterial functions in intes-
tinal cells such as regulation of antimicrobial peptides
(Kobayashi et al., 2005; Boughan et al., 2006).
Immunity
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with Disease Susceptibility
The importance of NOD1 an NOD2 is underscored by their
genetic association with human inflammatory diseases.
NOD1 polymorphisms are associated with the develop-
ment of atopic eczema, asthma, and increased serum
IgE concentrations (Hysi et al., 2005). The link between
NOD1 and asthma is intriguing in that microbial exposure
in childhood is known to protect against the development
of disease (Holt and Sly, 2002). Thus, NOD1-mediated
recognition of bacterial products in the skin or at mucosal
interfaces might regulate Th2 polarization and IgE con-
centrations.
Three common mutations (R702W, G908R, and
L1007insC) of amino acid residues near or within the
NOD2 LRR region constitute genetic risk factors for the
development of Crohn’s disease (Hugot et al., 2001;
Ogura et al., 2001a), a highly prevailing ailment character-
ized by abnormal T cell-mediated inflammation, particu-
larly in the intestinal tract. Biochemical and functional
studies in cell lines and primary monocytes revealed that
the disease-associated NOD2 variants exhibit a reduced
capacity to induce NF-kB activation and cytokine secre-
tion when stimulated with MDP (Inohara et al., 2003; Netea
et al., 2005b; van Heel et al., 2005). Several mechanisms
have been proposed to explain the link between NOD2
mutations and Crohn’s disease. They include (1) reduced
NOD2-dependent expression of microbicidal a-defensins
in Paneth cells (Kobayashi et al., 2005; Wehkamp et al.,
2005), (2) impaired recognition and clearance of bacteria
by intestinal phagocytes (Inohara et al., 2002), (3) dysregu-
lation of TLR2-mediated inflammation in intestinal macro-
phages and/or dendritic cells (Watanabe et al., 2006), and
(4) enhanced production of IL-1b (Maeda et al., 2005). The
presence of heightened TLR-induced cytokine responses
in macrophages and/or dendritic cells lacking NOD2 is
controversial, because several human and mouse studies
found the opposite (Fritz et al., 2005; Kobayashi et al.,
2005; Netea et al., 2005b; Park et al., 2007; van Heel
et al., 2005). Similarly, although mouse macrophages ex-
pressing the disease-associated L1007InsC NOD2 variant
exhibit increased IL-1b secretion when stimulated with
MDP (Maeda et al., 2005), monocytes isolated from
patients with the L1007InsC mutation display a marked
defect in IL-1b production (Li et al., 2004; Netea et al.,
2005a; van Heel et al., 2005). The notion that loss-of-
function mutations of NOD2, a PRR involved in host de-
fense and NF-kB activation, are associated with increased
inflammation is not surprising. For example, mutant mice
deficient in TLR2 or TLR4 exhibit increased inflammatory
responses after challenge with pathogenic bacteria
(Torres et al., 2004; Vazquez-Torres et al., 2004). The latter
observations can be explained by increased bacterial
burden in mutant tissues, which drives inflammation via
redundant and nonredundant PRR signaling pathways.
Similarly, conditional deletion of NEMO, a protein critical
for NF-kB activation, in intestinal epithelial cells develop
spontaneous colitis associated with the presence of bac-
teria in the lamina propia (Nenci et al., 2007). Collectively,the results suggest that NOD2 mutations may lead to im-
paired clearance of commensal bacteria, leading to inap-
propriate inflammatory responses in the intestinal tissue.
The Crohn’s disease-associated NOD2 variants are
also linked to increased incidence of graft-versus-host
disease (GVHD) and associated mortality in patients
undergoing allogeneic bone-marrow transplants (Elmaa-
gacli et al., 2006; Granell et al., 2006; Holler et al., 2004).
Although the mechanism involved remains unclear, abnor-
mal innate immune response to translocated intestinal
flora might be important, because the increased mortality
associated with GVHD was not seen after decontamina-
tion of the gut microflora (Elmaagacli et al., 2006). Finally,
missense mutations in the NOD region of NOD2 underlie
Blau syndrome (Miceli-Richard et al., 2001) and early-
onset sarcoidosis (Kanazawa et al., 2005), two autoso-
mally dominant disorders characterized by granuloma-
tous inflammation of multiple organs. These mutations
augment NOD2 activity, even in the absence of MDP (Cha-
maillard et al., 2003b; Tanabe et al., 2004), suggesting that
they represent gain-of-function mutations, in line with the
dominant mode of inheritance of these granulomatous
diseases. Clearly, further studies are needed to under-
stand the molecular pathways linking NOD2 mutations
with the development of inflammatory diseases.
The Inflammasomes Mediate Caspase-1
Activation
Whereas NOD1 and NOD2 stimulation leads to activation
of NF-kB and MAP kinases, the NLR proteins Ipaf, Nalp1,
and Cryopyrin are involved in activation of inflammatory
caspases. These evolutionarily conserved proteases are
produced as zymogens with a prodomain of variable
length followed by a large and small catalytic subunit
(Lamkanfi et al., 2002). The prodomain of the prototypical
inflammatory caspase-1 encodes a CARD, also present in
the C terminus of NOD1, NOD2, and RICK. Caspase-1 is
recruited to large multiprotein complexes known as ‘‘in-
flammasomes’’ through homotypic interactions with the
CARD motif in the adaptor ASC (Martinon et al., 2002).
This bipartite CARD-PYD protein bridges the association
of caspase-1 to the NLR proteins Nalp1 and Cryopyrin
in the inflammasomes and therefore plays a major role in
the activation of caspase-1 and the subsequent matura-
tion of the inflammatory cytokines IL-1b and IL-18 (Maria-
thasan et al., 2004; Martinon et al., 2002). Our knowledge
on the Ipaf, Nalp1, and Cryopyrin inflammasomes has
substantially advanced in the last few years and will be
reviewed below.
The Ipaf Inflammasome
Ipaf rapidly activates caspase-1 when it senses the intra-
cellular pathogens Salmonella typhimurium or Legionella
pneumophila. Indeed, caspase-1 activation is largely abol-
ished in Ipaf-deficient macrophages infected with these
intracellular pathogens (Amer et al., 2006; Franchi et al.,
2006; Mariathasan et al., 2006; Miao et al., 2006). Flagellin
was identified as the bacterial molecule that is sensed by
Ipaf, and flagellin-deficient bacteria are compromised in
Immunity 27, October 2007 ª2007 Elsevier Inc. 553
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ReviewFigure 2. Ligands and Composition of
the Caspase-1 Inflammasomes
Recognition of PAMPs by TLRs induces syn-
thesis of the IL-1b precursor through activation
of NF-kB. Bacteria and bacterial products en-
ter the cytosol via pore-forming toxins, type
III or IV secretion systems, or ATP-mediated
activation of the pannexin-1 pore. Activation
of NLRs by cytosolic PAMPs results in the for-
mation of caspase-1-activating inflamma-
somes independently of TLRs. The inflamma-
some adaptor ASC is required for recruitment
of caspase-1, although its role in the Nalp1b in-
flammasome needs to be confirmed. Salmo-
nella and Legionella flagellin are sensed by
Ipaf, whereas mouse Nalp1b recognizes an-
thrax lethal toxin. Cryopyrin/Nalp3 mediates
caspase-1 activation in response to a wide va-
riety of microbial components and the endoge-
nous danger signal uric acid. Francisella induce
ASC-dependent caspase-1 activation through
an NLR, the identity of which is unknown. Ac-
tive caspase-1 processes the IL-1b precursor
into the mature cytokine, which is secreted
through an unknown mechanism.their capability to induce caspase-1 activation and secre-
tion of IL-1b (Amer et al., 2006; Franchi et al., 2006; Miao
et al., 2006; Ren et al., 2006). A functional bacterial secre-
tion system (type III for S. typhimurium and type IV for
L. pneumophila) delivers flagellin to the cytosol, although
the molecular mechanism of translocation remains
unclear. The finding that recombinant purified flagellin
induces Ipaf-dependent caspase-1 activation when deliv-
ered directly into the cytosol (Amer et al., 2006; Franchi
et al., 2006; Miao et al., 2006) indicates that the cytosolic
presence of flagellin is essential and sufficient for Ipaf ac-
tivation (Figure 2). Interestingly, the extracellular flagellin
receptor TLR5 is not required for Ipaf-mediated detection
of cytosolic flagellin and subsequent activation of cas-
pase-1 (Amer et al., 2006; Franchi et al., 2006; Miao
et al., 2006). These results demonstrate that TLR5 and
Ipaf represent two flagellin receptors that have evolved
to control distinct signaling pathways (NF-kB activation
and caspase-1 activation, respectively) when the host is
infected with Salmonella or Legionella.
Naip5 is a NLR protein that structurally resembles Ipaf,
except for the three BIR motifs that replace the N-terminal
CARD in Ipaf (Inohara et al., 2005). Genetic studies identi-
fied mutations in the NLR protein Naip5 that underlie the
susceptibility of A/J mice to Legionella infection (Diez
et al., 2003; Wright et al., 2003). A critical step in control-
ling Legionella replication is the fusion of the Legionella-
containing vacuole (LCV) with lysosomes (Fortier et al.,
2005). The latter is mediated, at least in part, by the recog-
554 Immunity 27, October 2007 ª2007 Elsevier Inc.nition of bacterial flagellin, delivered to the cytosol via
a type IV secretion system (Amer et al., 2006; Molofsky
et al., 2006; Ren et al., 2006; Zamboni et al., 2006). Con-
sistently, flagellin-deficient Legionellamultiply inside mac-
rophages from mouse strains that are normally restrictive
to bacterial replication (Amer et al., 2006; Molofsky et al.,
2006; Ren et al., 2006; Zamboni et al., 2006). Initial studies
of macrophages infected with relatively high numbers of
Legionella suggested that Naip5 controls replication of
the bacterium via caspase-1-mediated cell death (Zam-
boni et al., 2006). However, recent studies under condi-
tions that allow exponential bacterial growth indicate
that Ipaf, but not Naip5, senses the presence of flagellin in-
side the host cell and promotes LCV-lysosome fusion
through the activation of caspase-1 (Amer et al., 2006).
In contrast to Ipaf, the role of Naip5 in the regulation of
Legionella replication is less clear. A/J macrophages
that express mutated Naip5 alleles were found to have im-
paired fusion of Legionella-containing phagosomes with
lysosomes (Fortier et al., 2006), raising the possibility
that Naip5 controls caspase-1 activation. However, stud-
ies with Naip5 transgenic mice recently demonstrated that
Naip5 restrict Legionella growth independent of flagellin
and caspase-1 activation (Lamkanfi et al., 2007). Further
characterization of the Naip5 pathway is required to fully
understand the mechanisms restricting this intracellular
pathogen. Legionella restriction was recently reported to
require type I interferons and TNF-a in addition to the
Ipaf and Naip5 pathways (Coers et al., 2007). The
Immunity
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restrict Legionella replication is unknown but, in the case
of TNF-a, may require gene transcription via NF-kB (Coers
et al., 2007). Clearly, restriction of Legionella growth is
more complex than previously thought and requires the
concerted action of multiple pathways to counter the
propagation of this pathogen.
The Nalp1 Inflammasome
Death associated with systemic anthrax infections is be-
lieved to be due to the Bacillus anthracis lethal toxin (LT)
(Ezzell et al., 1984). This dimeric toxin consists of the pro-
tective antigen subunit, a pore-forming toxin that delivers
the proteolytic subunit lethal factor into the cytosol of
infected cells (Leppla et al., 1999). Macrophages from
C57BL/6 and multiple other inbred mice were found to
be resistant to LT-induced death, whereas 129/S1 macro-
phages are highly susceptible (Friedlander, 1986). This
susceptibility trait was mapped to a single dominant locus
on mouse chromosome 11 that was designated Ltxs1
(Roberts et al., 1998). More recently, Boyden and Dietrich
identified mutations in the Nalp1b gene as the key deter-
minant of LT susceptibility in mice (Boyden and Dietrich,
2006). Five distinct Nalp1b alleles were identified in the
18 mouse strains analyzed so far, demonstrating the ex-
tremely polymorphic nature of the Nalp1b gene (Boyden
and Dietrich, 2006). Two alleles were found in susceptible
strains, whereas the three remaining alleles correlated
with LT-resistant mice. Morpholinos targeting of Nalp1b
rendered LT-sensitive macrophages resistant. In addition,
LT-induced toxicity was restored in macrophages ex-
pressing the susceptible Nalp1b allele from 129/S1 mice
in a LT-resistant background (Boyden and Dietrich,
2006). These studies established that a functional Nalp1b
allele is required for LT-induced toxicity in mouse macro-
phages (Figure 2). Therefore, inflammatory caspases were
suggested to mediate LT-dependent killing of macro-
phages downstream of Nalp1b. Indeed, caspase-1 acti-
vation is activated only in LT-sensitive macrophages,
and caspase-1-deficient macrophages are protected
from LT-induced death, even in the presence of a sensitive
Nalp1b allele (Boyden and Dietrich, 2006). In contrast to
mouse Nalp1b, human NALP1 interacts with ASC and
the adaptor protein CARDINAL to recruit and activate
the inflammatory caspase-1 and -5 (Agostini et al., 2004;
Faustin et al., 2007). Recently, Reed and colleagues
showed that the antiapoptotic Bcl-2 members Bcl-2 and
Bcl-XL specifically interact with human Nalp1 and prevent
Nalp1-mediated caspase-1 activation (Bruey et al., 2007).
It would be interesting to determine whether Bcl-2 inhibits
LT-induced cytotoxicity. Moreover, the mechanism by
which mutations in Nalp1b confer protection against
LT-induced macrophage killing warrants further research.
The Cryopyrin Inflammasome
Cryopyrin and the inflammasome adaptor ASC are re-
quired for caspase-1 activation in response to microbial
products with diverse molecular structures such as LPS,
peptidoglycan, and lipoteichoic acid when combinedwith millimolar concentrations of ATP (Kanneganti et al.,
2006a, 2007; Mariathasan et al., 2006; Sutterwala et al.,
2006). Bacterial RNA and the imidazoquinoline com-
pounds R837 and R848 alone induce IL-1b secretion
(Kanneganti et al., 2006b), but a brief pulse with ATP mark-
edly enhances caspase-1 activation and IL-1bmaturation.
The mechanism by which microbial ligands are sensed
by cryopyrin in the presence of ATP has remained, until
recently, unclear. ATP triggers the potassium-selective
channel of the purinergic P2X7 receptor to open (Pelegrin
and Surprenant, 2006a). Recent studies have revealed
that the rapid activation of P2X7 receptor is followed by
the gradual opening of a larger pore attributed to the hemi-
channel pannexin-1, which is recruited upon P2X7 recep-
tor activation (Locovei et al., 2007; Pelegrin and Surpren-
ant, 2006a, 2006b). Notably, pannexin-1 was found to be
critical for caspase-1 activation and IL-1b secretion in
LPS-stimulated macrophages pulsed with ATP (Pelegrin
and Surprenant, 2006b), suggesting that pannexin-1
mediates somehow the activation of the cryopyrin inflam-
masome. Further studies revealed that microbial mole-
cules are sensed by cryopyrin in the cytosol to activate
caspase-1 independently of TLR signaling through the
pannexin-1. Indeed, the TLR4 ligand LPS induced activa-
tion of caspase-1 in macrophages deficient in MyD88,
TRIF, or TLR4 (Kanneganti et al., 2007; Yamamoto et al.,
2004). Nevertheless, TLRs are still essential for NF-kB-
dependent production of pro-IL-1b (Kanneganti et al.,
2007). In this model, pannexin-1 delivers bacterial
molecules into the cytosol where they are sensed by
cryopyrin.
The mechanism by which bacterial molecules activate
caspase-1 through cryopyrin in the cytosol remains un-
clear. One possibility is that cryopyrin directly senses the
presence of microbial stimuli in the cytosol. Although there
is no evidence for a physical interaction between cryo-
pyrin and microbial molecules, purified NALP1 has been
shown to mediate caspase-1 activation in response to
MDP (Faustin et al., 2007), suggesting that under certain
conditions, PAMPs may directly activate NLRs. Another
possibility is that the sensing of PAMPs via cryopyrin is in-
direct, as shown for several plant NLR orthologs (Mackey
et al., 2002, 2003). The latter is more consistent with the
fact that cryopyrin induces caspase-1 activation in re-
sponse to a plethora of bacterial ligands in the presence
of ATP. Therefore, the presence of PAMPs in the cytosol
might be recognized by one or more host factors that in-
duce the activation and assembly of the cryopyrin inflam-
masome. A variation of the latter model is that bacterial
molecules in the presence of ATP induce changes in the
intracellular ionic milieu or other cellular events that are
sensed by cryopyrin. Stimulation of the P2X7 receptor
with ATP induces K+ efflux, a signal that has been impli-
cated in cryopyrin-mediated caspase-1 activation (Fran-
chi et al., 2007). A role for K+ efflux in caspase-1 activation
has been suggested by the observation that the response
to LPS and ATP is abrogated in the presence of high extra-
cellular K+ (Burns et al., 2003; Kahlenberg and Dubyak,
2004). A caveat of these experiments is that high
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addition, ATP stimulation does not trigger caspase-1 acti-
vation in the absence of prestimulation with microbial
stimuli such as LPS (Kanneganti et al., 2007), indicating
that reduction of intracellular K+ alone is not sufficient to
activate caspase-1. Furthermore, pannexin-1 inhibition
abolishes caspase-1 activation, but not K+ efflux in mac-
rophages stimulated with LPS and ATP (Pelegrin and Sur-
prenant, 2006b). Finally, infection of macrophages with
intracellular bacteria including Salmonella and Listeria
induces caspase-1 activation independently of intracellu-
lar K+ fluctuations (Franchi et al., 2007; Petrilli et al., 2007).
Collectively, these results suggest that intracellular K+
may reduce the threshold for caspase-1 activation but
does not play an essential role in inducing NLR-mediated
caspase-1 activation.
Cryopyrin mutations are associated with inflammatory
diseases in humans. The finding that monosodium urate
(MSU) and calcium pyrophosphate dehydrate (CPPD)
crystals require cryopyrin, but not ATP, to activate cas-
pase-1 suggests a role for the cryopyrin inflammasome
in the pathogenesis of gout and pseudogout (Martinon
et al., 2006). Gain-of-function mutations within the NOD
domain of cryopyrin are associated with three auto-
inflammatory disorders characterized by skin rashes and
prolonged episodes of fever (Figure 2). These hereditary
periodic-fever syndromes are known as Muckle-Wells
syndrome (MWS), familial cold autoinflammatory syn-
drome (FACS), and neonatal-onset multisystem inflamma-
tory disease (NOMID), and they are collectively referred to
as cryopyrin-associated periodic syndromes (CAPS)
(Martinon and Tschopp, 2004). Functional studies re-
vealed that the disease-associated cryopyrin mutations
enhance caspase-1 activation and IL-1b secretion (Dowds
et al., 2004). Consistent with these observations, mononu-
clear cells from CAPS patients spontaneously secrete
IL-1b and IL-18 (Agostini et al., 2004; Rosengren et al.,
2007), and IL-1 receptor antagonists proved to be an effec-
tive treatment for these autoinflammatory syndromes
(Hoffman et al., 2004). These findings warrant further study
of the mechanisms controlling the activation of the cryo-
pyrin inflammasome.
The Francisella-Sensing Inflammasome
The causative agent of tularemia, the Gram-negative
coccobacillus Francisella tularensis, escapes from the
phagosome to replicate in the cytosol of infected macro-
phages. The in vivo response to Franciscella requires
ASC and caspase-1, as indicated by the fact that bacterial
burdens and mortality are markedly increased in ASC-de-
ficient and caspase-1-deficient mice (Mariathasan et al.,
2005). Mechanistically, Franciscella mutants that cannot
escape the vacuole are incapable of activating caspase-
1, thus linking phagosomal escape to the induction of
caspase-1 activation (Gavrilin et al., 2006). Franciscella in-
duces caspase-1 activation through ASC, but cryopyrin
and Ipaf are dispensable (Mariathasan et al., 2005,
2006). It is not known how the NLR senses the Franciscella
in the cytosol to mediate caspase-1 activation. Also un-
556 Immunity 27, October 2007 ª2007 Elsevier Inc.known is the Franciscella-derived molecule that triggers
ASC-dependent caspase-1 activation. Recently, type I in-
terferon signaling was shown to be important for Francis-
cella-induced caspase-1 activation (Henry et al., 2007).
However, the mechanism by which type I interferons con-
trols caspase-1 activation in response to Franciscella
needs to be elucidated.
Concluding Remarks
It has now become evident that NLRs fulfill important roles
in innate immune responses. However, several important
questions remain, including the mechanism by which bac-
terial molecules enter the cytosol to elicit NLR recognition
as well as how NLRs interact with other PRRs to mount an
effective immune response against pathogens. In addi-
tion, it is currently unclear whether NOD1, NOD2, Ipaf,
and Cryopyrin serve as direct receptors of PAMPs or in-
stead detect modifications of host factors or cellular re-
sponses induced by the presence of microbial molecules
in the cytosol. In this respect, the homologous R proteins
in plants were suggested to recognize microbial compo-
nents largely through an indirect mechanism (Mackey
et al., 2002, 2003). Undoubtedly, elucidating how NLRs
recognize microbial products will provide new insights
into the mechanisms governing innate immunity.
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